Biomarin Pharmaceuticals (NQ: BMRN )

66.60 +0.71 (+1.08%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
November 27, 2017
Form CT ORDER
Source: SEC/Edgar
November 16, 2017
Form 10-Q/A
Source: SEC/Edgar
November 12, 2017
Form 8-K
Source: SEC/Edgar
October 25, 2017
Form 8-K
Source: SEC/Edgar
October 02, 2017
Form 8-K
Source: SEC/Edgar
August 10, 2017
Form 424B5
Source: SEC/Edgar
August 07, 2017
Form 305B2
Source: SEC/Edgar
August 07, 2017
Form 8-K
Source: SEC/Edgar
August 01, 2017
Form DEF 14A
Source: SEC/Edgar
April 24, 2017
Form DEFA14A
Source: SEC/Edgar
April 24, 2017
Form 8-K
Source: SEC/Edgar
April 12, 2017
Form PRE 14A
Source: SEC/Edgar
April 10, 2017
Form CT ORDER
Source: SEC/Edgar
April 05, 2017
Form CT ORDER
Source: SEC/Edgar
April 04, 2017
Form 8-K
Source: SEC/Edgar
February 22, 2017
Form SC 13G/A
Source: SEC/Edgar
February 13, 2017
Form SC 13G/A
Source: SEC/Edgar
February 13, 2017
Form SC 13G/A
Source: SEC/Edgar
February 12, 2017
Form SC 13G/A
Source: SEC/Edgar
February 09, 2017
Form SC 13G
Source: SEC/Edgar
January 29, 2017
Form SC 13G/A
Source: SEC/Edgar
January 18, 2017
Form 8-K
Source: SEC/Edgar
December 18, 2016
Form 8-K
Source: SEC/Edgar
December 08, 2016
Form 8-K
Source: SEC/Edgar
December 01, 2016
Form 8-K
Source: SEC/Edgar
October 26, 2016
Form 8-K
Source: SEC/Edgar
August 10, 2016
Form 424B5
Source: SEC/Edgar
August 09, 2016
Form 424B5
Source: SEC/Edgar
August 08, 2016
Form S-3ASR
Source: SEC/Edgar
August 07, 2016
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.